electroCore, Inc. (ECOR) Stock Analysis & Investment Frameworks
electroCore, Inc. (ECOR) stock analysis on Invetso. Review electroCore, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
electroCore, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
electroCore, Inc. Key Financial Metrics
- Market Cap: $65.37M
- Revenue: $32.03M
- ROE: 498.83%
- ROIC: -170.03%
- Dividend Yield: N/A
About electroCore, Inc.
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
electroCore, Inc. Investment Frameworks
Invetso analyzes electroCore, Inc. (ECOR) across the following frameworks:
- electroCore, Inc. 10Y Growth Potential
- electroCore, Inc. Scenario Analysis
- electroCore, Inc. Risks & Opportunities
- electroCore, Inc. Economic Moat
- electroCore, Inc. Business Model
- electroCore, Inc. Management
- electroCore, Inc. SWOT Analysis
- electroCore, Inc. Porter's 5 Forces
- electroCore, Inc. PESTLE Analysis
- electroCore, Inc. ESG Analysis